Related Experiment Video
Updated: May 22, 2026

Evaluation of Polymeric Gene Delivery Nanoparticles by Nanoparticle Tracking Analysis and High-throughput Flow Cytometry
Published on: March 1, 2013
Dendrimer type bio-reducible polymer for efficient gene delivery
Hye Yeong Nam1, Kihoon Nam, Minhyung Lee
1Center for Controlled Chemical Delivery, Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, Salt Lake City, UT 84112, United States.
Researchers developed a new polymer, PAM-ABP, for gene delivery. This advanced polymer effectively condenses DNA, improving cellular uptake and transfection efficiency for potential clinical gene therapy applications.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Gene Therapy
Background:
- Low molecular weight arginine-grafted bio-reducible poly(disulfide amine) (ABP) has limitations as a gene delivery carrier.
- Poly(amido amine) (PAMAM) dendrimers offer a versatile platform for polymer modification.
Purpose of the Study:
- To synthesize a high molecular weight bio-reducible polymer, PAM-ABP, by incorporating ABP into PAMAM dendrimers.
- To evaluate the efficacy of the novel PAM-ABP as a gene delivery carrier.
- To compare the performance of PAM-ABP with ABP alone.
Main Methods:
- Synthesis of PAM-ABP by grafting ABP onto PAMAM dendrimers.
- Characterization of PAM-ABP's ability to condense plasmid DNA into nanosized polyplexes.
- Assessment of cellular uptake and transfection efficiency of PAM-ABP/DNA polyplexes.
- Evaluation of polyplex stability in the presence of reducing agents.
Main Results:
- PAM-ABP exhibited superior DNA condensing ability, forming compact nanosized polyplexes.
- These polyplexes demonstrated enhanced cellular uptake compared to ABP alone.
- PAM-ABP polyplexes showed increased resistance to reducing agents.
- Significantly greater transfection efficiency was observed with PAM-ABP compared to ABP.
Conclusions:
- The newly developed high molecular weight PAM-ABP is an effective gene delivery carrier.
- PAM-ABP polyplexes offer advantages in DNA condensation, cellular uptake, and transfection efficiency.
- PAM-ABP represents a promising candidate for clinical gene therapy applications.
Related Concept Videos
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Recombinant DNA
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...

